2010
» Volume 9, Issue 4
pp. 269-398
» Volume 9, Issue 3
pp. 167-268
» Volume 9, Issue 2
pp. 87-166
» Volume 9, Issue 1
pp. 1-86
2009
» Volume 8, Issue 6
pp. 453-526
» Volume 8, Issue 5
pp. 369-452
» Volume 8, Issue 4
pp. 285-367
» Volume 8, Issue 3
pp. i-284
» Volume 8, Issue 2
pp. 107-192
» Volume 8, Issue 1
pp. 1-106
2008
» Volume 7, Issue 6
pp. 469-554
» Volume 7, Issue 5
pp. 363-468
» Volume 7, Issue 4
pp. 269-362
» Volume 7, Issue 3
pp. 187-268
» Volume 7, Issue 2
pp. 91-186
» Volume 7, Issue 1
pp. 1-90
2007
» Volume 6, Issue 6
pp. 401-514
» Volume 6, Issue 5
pp. 313-399
» Volume 6, Issue 4
pp. 227-312
» Volume 6, Issue 3
pp. 151-226
» Volume 6, Issue 2
pp. 91-150
» Volume 6, Issue 1
pp. 1-90
2006
» Volume 5, Issue 6
pp. 391-475
» Volume 5, Issue 5
pp. 317-389
» Volume 5, Issue 4
pp. 235-316
» Volume 5, Issue 3
pp. 159-233
» Volume 5, Issue 2
pp. 61-158
» Volume 5, Issue 1
pp. 1-59
2005
» Volume 4, Issue 6
pp. 303-353
» Volume 4, Issue 5
pp. 223-302
» Volume 4, Issue 4
pp. 151-221
» Volume 4, Issue 3
pp. 109-150
» Volume 4, Issue 2
pp. 55-107
» Volume 4, Issue 1
pp. 1-53
2004
» Volume 3, Issue 12
pp. 291-306
» Volume 3, Issue 11
pp. 265-290
» Volume 3, Issue 10
pp. 234-259
» Volume 3, Issue 9
pp. 202-227
» Volume 3, Issue 8
pp. 170-195
» Volume 3, Issue 7
pp. 139-163
» Volume 3, Issue 6
pp. 111-132
» Volume 3, Issue 5
pp. 87-104
» Volume 3, Issue 4
pp. 63-80
| TAF Preventive Medicine Bulletin. 2010; 9(4): 355-360 From Proof of Effects to Proof of Efficacy for Compound–Drug Preparations André-Michael Beer.Abstract
To raise the level of acceptance of phytotherapy we must target and enhance research studies of the effects and efficacy of herbal medicines and initiate a closer collaboration between clinical and experimental research. The special features of phytopharmaceuticals dictate a specific course of investigations: to the effects, the mode of action and the efficacy using in-vitro and in vivo experiments, human pharmacological studies and finally randomised clinical trials. Using the example of our own scientific work we demonstrate the meaningfullness of this strategy. Key words: Phytopharmaceuticals, efficacy, phytotherapy
Etkinin Kanıtlanmasından Etkililiğin Kanıtlanmasına Bileşik-İlaç Preparatları Özet
Fitoterapi kabul düzeyinin yükselmesi nedeniyle, bitkisel ilaçların etkilerinin ve etkililiklerinin araştırılması ve bu konuda klinik ve deneysel araştırmaların geliştirilmesi, bu araştırmaların aralarında daha yakın bir işbirliğinin başlatması hedef olmalıdır. Fitofarmasötiklerin özellikleri; belirli bir inceleme sistemini gerektirmektedir: etkileri, eylem modu, in-vitro ve in vivo deneylerde etkililik, insan farmakolojik çalışmaları ve nihayet randomize klinik çalışmalar. Bu çalışmada kendi yaptığımız bilimsel çalışma örneği kullanılarak, bu stratejinin anlamlılığının gösterilmesi amaçlamıştır. Anahtar Kelimeler: fitofarmasötikler, etkililik, fitoterapi
Article Statistics
Viewed: 20 Downloaded: 20 Emailed: 0 | Howto Cite this Article | | Pubmed Style Beer A. From Proof of Effects to Proof of Efficacy for Compound–Drug Preparations. TAF Prev Med Bull. 2010; 9(4): 355-360.
Web StyleBeer A. From Proof of Effects to Proof of Efficacy for Compound–Drug Preparations. www.scopemed.org/?mno=1343 [Access: September 03, 2010]
AMA (American Medical Assoc.) StyleBeer A. From Proof of Effects to Proof of Efficacy for Compound–Drug Preparations. TAF Prev Med Bull. 2010; 9(4): 355-360.
Vancouver/ICMJE StyleBeer A. From Proof of Effects to Proof of Efficacy for Compound–Drug Preparations. TAF Prev Med Bull. (2010), [cited September 03, 2010]; 9(4): 355-360.
Harvard StyleBeer, A. (2010) From Proof of Effects to Proof of Efficacy for Compound–Drug Preparations. TAF Prev Med Bull, 9 (4), 355-360.
|
|
PDF Fulltext (448 KB)
